Company intelligence / Profile preview

GALY

Boston, Massachusetts, United Statesgaly.co ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

GALY has successfully developed lab-grown cotton using cellular agriculture, with proof-of-concept fabrics produced. The company has raised significant funding to scale its technology and expand into other crops. It has won major innovation awards (H&M Global Change Award, LVMH Innovation Award) and signed long-term sourcing agreements with industry partners. No clinical results are relevant as the business is non-healthcare focused[1][2][7].

Industry: Non-Drug Biotech

Partnerships

Inditex/ZARA (strategic investment/shareholder)Long-term sourcing agreements with undisclosed partners in textiles/fashion industry

Beyond the preview

Go deeper on GALY.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GALY.

Explore the full profile